메뉴 건너뛰기




Volumn 68, Issue 12, 2007, Pages 1988-1989

Treatment of cognitive deficits in schizophrenia with atomoxetine: A case report [4]

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; RISPERIDONE;

EID: 38049054669     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v68n1222d     Document Type: Letter
Times cited : (2)

References (8)
  • 1
    • 23944483535 scopus 로고    scopus 로고
    • Cognition in schizophrenia: Impairments, determinants, and functional importance
    • Bowie CR, Harvey PD. Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr Clin North Am 2005;28:613-633
    • (2005) Psychiatr Clin North Am , vol.28 , pp. 613-633
    • Bowie, C.R.1    Harvey, P.D.2
  • 2
    • 26444452685 scopus 로고    scopus 로고
    • Atomoxetine and Stroop task performance in adult attention-deficit/hyperactivity disorder
    • Faraone SV, Biederman J, Spencer T, et al. Atomoxetine and Stroop task performance in adult attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2005;15:664-670
    • (2005) J Child Adolesc Psychopharmacol , vol.15 , pp. 664-670
    • Faraone, S.V.1    Biederman, J.2    Spencer, T.3
  • 3
    • 2442586388 scopus 로고    scopus 로고
    • Potential noradrenergic targets for cognitive enhancement in schizophrenia
    • Friedman JI, Stewart DG, Gorman JM. Potential noradrenergic targets for cognitive enhancement in schizophrenia. CNS Spectr 2004;9:350-355
    • (2004) CNS Spectr , vol.9 , pp. 350-355
    • Friedman, J.I.1    Stewart, D.G.2    Gorman, J.M.3
  • 4
    • 4644226347 scopus 로고    scopus 로고
    • Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial
    • Kelsey DK, Sumner CR, Casat CD, et al. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics 2004;114:E1-E8
    • (2004) Pediatrics , vol.114
    • Kelsey, D.K.1    Sumner, C.R.2    Casat, C.D.3
  • 5
    • 0023149820 scopus 로고
    • Use of pattern analysis to identify true drug response: A replication
    • Quitkin FM, Rabkin JD, Markowitz JM, et al. Use of pattern analysis to identify true drug response: a replication. Arch Gen Psychiatry 1987;44:259-264
    • (1987) Arch Gen Psychiatry , vol.44 , pp. 259-264
    • Quitkin, F.M.1    Rabkin, J.D.2    Markowitz, J.M.3
  • 6
    • 0036848458 scopus 로고    scopus 로고
    • Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder
    • Bymaster FP, Katner JS, Nelson DL, et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002;27:699-711
    • (2002) Neuropsychopharmacology , vol.27 , pp. 699-711
    • Bymaster, F.P.1    Katner, J.S.2    Nelson, D.L.3
  • 7
    • 0030666362 scopus 로고    scopus 로고
    • Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine
    • Tanda G, Pontieri FE, Frau R, et al. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 1997;9:2077-2085
    • (1997) Eur J Neurosci , vol.9 , pp. 2077-2085
    • Tanda, G.1    Pontieri, F.E.2    Frau, R.3
  • 8
    • 0036920908 scopus 로고    scopus 로고
    • Management of ADHD in adults
    • Adler AL, Chua CH. Management of ADHD in adults. J Clin Psychiatry 2002;63(suppl 12):29-35
    • (2002) J Clin Psychiatry , vol.63 , Issue.SUPPL. 12 , pp. 29-35
    • Adler, A.L.1    Chua, C.H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.